Streetbeat News

Stock Prices

EXEL

Exelixis (NASDAQ:EXEL) has received mixed analyst ratings over the past three months, with a recent positive shift in price targets. Analysts have raised their average 12-month price target by 7% to $30.25. The company shows strong financial performance with high revenue growth, net margin, ROE, and ROA, and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

VSCO

Victoria's Secret (NYSE:VSCO) has been analyzed by 17 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has increased by 11.9% to $24.82. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Despite challenges like a -0.7% revenue decline and high debt-to-equity ratio, the company shows strong ROE.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

WULF

TeraWulf (NASDAQ:WULF) has seen unusual options activity, with a significant bearish sentiment from large investors. The options trades are predominantly bearish, with 76% of the trades reflecting this sentiment. The stock is currently trading at $6.02, up 14.89%, but analysts have mixed ratings with price targets ranging from $5 to $10.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

NOW

ServiceNow (NYSE:NOW) has seen unusual options activity, with significant trades indicating a mixed sentiment among investors. The options trades suggest a price range of $700 to $970 for the stock over the next three months. Analysts maintain a positive outlook with target prices ranging from $1000 to $1100.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

KEY

Analysts have provided mixed evaluations for KeyCorp (NYSE:KEY) over the past three months, with a range of ratings from bullish to bearish. The average 12-month price target has increased to $18.46, reflecting a 5.97% rise. Despite challenges in revenue growth and returns, KeyCorp maintains a strong net margin and balanced debt management.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

MFG

MUFG

SMFG

Japanese banks' shares are trading lower following the release of data showing a slowdown in Japan's September core CPI.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 7:00 pm

RNA

Avidity Biosciences (NASDAQ:RNA) received mixed ratings from 10 analysts, with a majority being somewhat bullish. The average 12-month price target increased to $71.5, indicating a positive outlook. Despite this, the company faces financial challenges, including a decline in revenue growth and low profitability metrics.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

UTHR

Analysts have mixed views on United Therapeutics (NASDAQ:UTHR) with recent ratings showing a majority bullish sentiment. The average 12-month price target has increased by 18.57% to $409.57. United Therapeutics has shown strong financial performance with a 19.85% revenue growth rate and high net margins.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm

SN

Analysts have varied ratings for SharkNinja (NYSE:SN), with a mix of bullish and somewhat bullish sentiments. Recent analyst actions include raised price targets and ratings, reflecting positive expectations. SharkNinja's financial health is strong, with notable revenue growth, efficient cost management, and a conservative debt approach.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 7:00 pm